The rapid diagnosis of septicaemic melioidosis will have an impact on reduction of mortality. Currently, this relies almost exclusively upon culture of the causative agent Burkholderia pseudomallei from clinical samples. In acute sepsis, blood is the preferred specimen for culture and therefore should be the target for a rapid diagnostic tool. A lateral flow immunoassay (LFI) for the detection of B. pseudomallei antigen has been developed. This was compared with molecular detection using the targets T3SS1 and IpxO. Forty-five clinical samples of EDTA blood, which were culture-positive, were tested using both modalities. The LFI had a sensitivity of 40 %, whilst molecular detection had a sensitivity of 20 %. The poor performance of molecular detection has been described previously and is largely related to the use of whole-blood specimens collected into blood tubes containing EDTA. Whilst suboptimal, the LFI would be an adjunct in the rapid diagnosis of melioidosis.
EkpoP., RungpanichU., PongsunkS., NaigowitP., PetkanchanapongV.2007; Use of protein-specific monoclonal antibody-based latex agglutination for rapid diagnosis of Burkholderia pseudomallei infection in patients with community-acquired septicemia. Clin Vaccine Immunol 14:811–812 [View Article][PubMed]
GilmoreG., BarnesJ., KetheesanN., NortonR.2007; Use of antigens derived from Burkholderia pseudomallei, B thailandensisB. cepacia in the indirect hemagglutination assay for melioidosis. Clin Vaccine Immunol 14:1529–1531 [View Article][PubMed]
HoughtonR.L., ReedD.E., HubbardM.A., DillonM.J., ChenH., CurrieB.J., MayoM., SarovichD.S., TheobaldV., other authors. 2014; Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis 8:e2727 [View Article][PubMed]
KunakornM., RaksakaitK., SethaudomC., SermswanR.W., DharakulT.2000; Comparison of three PCR primer sets for diagnosis of septicemic melioidosis. Acta Trop 74:247–251 [View Article][PubMed]
MalczewskiA.B., OmanK.M., NortonR.E., KetheesanN.2005; Clinical presentation of melioidosis in Queensland, Australia. Trans R Soc Trop Med Hyg 99:856–860 [View Article][PubMed]
MeumannE.M., NovakR.T., GalD., KaestliM.E., MayoM., HansonJ.P., SpencerE., GlassM.B., GeeJ.E., other authors. 2006; Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 44:3028–3030 [View Article][PubMed]
SupapromC., WangD., LeelayuwatC., ThaewpiaW., SusaengratW., KohV., OoiE.E., LertmemongkolchaiG., LiuY.2007; Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens. J Clin Microbiol 45:2894–2901 [View Article][PubMed]